The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study

Overview of attention for article published in Frontiers in Pharmacology, March 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 133 followers.

3-16-2021: In a study just released today from China, after corticosteroids, azathioprine, methotrexate, cyclosporine, tacrolimus, and intravenous immunoglobulin had failed, Actemra (tocilizumab) was called in to rescue 11 patients with "refractory IMNMs"

16 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.